- Durada
- 01/01/2019 - 31/12/2022
- Coordinador
- Liverpool School of Tropical Medicine
- Finançadors
- EU Horizon 2020
- Pàgina web
- http://inteafrica.org/
The diseases affecting the African population have drastically changed in the last decades. Although acute infections continue to constitute a high burden, chronic diseases, which require regular lifelong care, now have an equal or higher burden.
Two of the chronic conditions of major concern are hypertension (the single largest risk factor for death, it has reached a prevalence of 20% in Africa), and diabetes (its prevalence in Africa is increasing rapidly and currently exceeds 5%).
This represents a huge challenge for Africa, where coverage of health services remains low. Less than 5% of people with diabetes or hypertension are thought to receive regular care.
INTE-Africa proposes to scale up provision for diabetes and hypertension in two countries in Africa (Uganda and Tanzania).
Objectives
The main objective of this implementation research project is to assess the effectiveness and feasibility of two approaches: scale up hypertension and diabetes integrated services alone, or in combination with HIV infection services.
The specific objectives are:
- Reorganise primary health care services so that diabetes and hypertension can be diagnosed and treated in dedicated chronic care clinics in two large regions (one in Tanzania and one in Uganda).
- Reorganise HIV clinics into chronic care clinics in 2 large regions (different from the above) so that they can diagnose and treat all three conditions: HIV, diabetes and hypertension.
- Decentralise care from health facilities to community posts for patients stable on treatment.
- Evaluate these approaches in terms of acceptability (by patients and community), number of patients treated and retained, clinical outcomes, costs of integrated care delivery, and cost-effectiveness (compared to current standard care).
- Use the data generated to develop national and global clinical guidelines for the provision of diabetes and hypertension care in low-resource settings.
- Describe the challenges faced by health services in delivering the integration models and disseminate this knowledge to improve practices and facilitate further scale up.
- Develop sustainable partnerships between researchers, government policy makers, public-private partnerships to facilitate the scale-up nationally.
- Disseminate the knowledge generated to facilitate effective control of diabetes and hypertension in low-resource settings.
Impact
This project is expected to catalyse the scale up of diabetes and hypertension services in the two countries and beyond. The model could also be replicated for other disease conditions, facilitating universal access to care and health coverage and optimizing the use of resources.
Total funding
€ 4.2 million
Our Team
Equip ISGlobal
-
Jeffrey Lazarus Head of the Public Health Liver Group
-
Camila Picchio Investigadora postdoctoral
Altres projectes
Veure projectes passatsANTICOV
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
COMBACTE
Combatent la Resistència Bacteriana a Europa
GAMA
Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting
Desenvolupament d'estratègies per a l'Eradicació de la Malaltia de Pian
Eradicació del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
MAMAH
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
ICARIA
Improving Care through Azithromycin Research for Infants in Africa
PreFIT
Predicting the Future: Incipient Tuberculosis
Predicting the Future: Incipient Tuberculosis
Encuesta serológica Cendea de Cizur
Cendea de Cizur
Projecte de Recerca en Resposta Immunitària i Epidemiologia de Malalties Infeccioses
Conèixer la propagació. Entendre la protecció
Stool4TB
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
TB-RECONNECT
Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status
SToolNIH
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
ALIA - Las ciudades y la salud
Planificación urbana, medio ambiente y salud | Clima y salud | Resistencias Antimicrobianas
END-VOC
ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)
TwinAir
Digital Twins Enabled Indoor Air Quality Management for Healthy Living
Estudio de la propagación de bacterias y genes de resistencia a los antibióticos en el ciclo integral del agua, en el área metropolitana de Barcelona
Propagación de la resistencia en aguas
Nuevos complejos de oro (III) frente a bacterias multirresistentes
Project Code: DTS21/00004
Desarrollo de dos nuevas estrategias terapéuticas (inhibidores de bombas de expulsion y ARN antisentido) activos frente a bacterias mutliresistentes
Más allá de la supresión vírica del VIH: un cuarto noventa para mejorar la salud de personas viviendo con el VIH en España
Project Code: PI20/01654
ENDÈMIC
Community knowledge generation through scientific culture, urban ecology and art
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
Hepatitis C Free Baleares
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
FLAVOBAC
Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias